Empagliflozin D8
| VS CAT No | VS-E009D02 |
| CAS No | NA |
| Mol.F. | C23H19D8ClO7 |
| Mol.Wt. | 459.0 |
| Inv. Status | Custom Synthesis |
Chemical Name: (2S,3R,4R,5S,6R)‐2‐[4‐chloro‐3‐({4‐[(2,2,5,5‐ D4)oxolan‐3‐yloxy](D4)phenyl}methyl)phenyl]‐6‐ (hydroxymethyl)oxane‐3,4,5‐triol
Shipping Temperature: Ambient
Country of Origin: India
Smiles: O[C@H]([C@H]1O)[C@@H](O[C@H](CO)[C@H]1O)C2=CC(CC3=C([2H])C([2H])=C(O[C@H]4CC([2H])([2H])OC4([2H])[2H])C([2H])=C3[2H])=C(Cl)C=C2
Empagliflozin D8 is chemically (2S,3R,4R,5S,6R)‐2‐[4‐chloro‐3‐({4‐[(2,2,5,5‐ D4)oxolan‐3‐yloxy](D4)phenyl}methyl)phenyl]‐6‐ (hydroxymethyl)oxane‐3,4,5‐triol. Empagliflozin D8 is supplied with detailed characterization data compliant with regulatory guideline. Empagliflozin D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Empagliflozin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.